Does the media refer more to TFX or KMTS?

In the previous week, Teleflex had 8 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 10 mentions for Teleflex and 2 mentions for Kestra Medical Technologies. Teleflex's average media sentiment score of 0.73 beat Kestra Medical Technologies' score of 0.58 indicating that Teleflex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Kestra Medical Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MMED or KMTS?

In the previous week, MiniMed Group had 4 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 6 mentions for MiniMed Group and 2 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.58 beat MiniMed Group's score of 0.44 indicating that Kestra Medical Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Kestra Medical Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor KMTS or HAE?

In the previous week, Haemonetics had 11 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 13 mentions for Haemonetics and 2 mentions for Kestra Medical Technologies. Haemonetics' average media sentiment score of 0.96 beat Kestra Medical Technologies' score of 0.58 indicating that Haemonetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Haemonetics 7 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media refer more to LIVN or KMTS?

In the previous week, LivaNova had 4 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 6 mentions for LivaNova and 2 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.58 beat LivaNova's score of 0.14 indicating that Kestra Medical Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Kestra Medical Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer KMTS or ITGR?

In the previous week, Integer had 17 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 19 mentions for Integer and 2 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.58 beat Integer's score of 0.37 indicating that Kestra Medical Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Kestra Medical Technologies (KMTS) Competitors

$26.92 +0.01 (+0.04%)

Closing price 08/25/2026 04:00 PM Eastern

Extended Trading

$25.72 -1.20 (-4.46%)

As of 08/25/2026 04:47 PM Eastern

Compare

KMTS vs. TFX, MMED, HAE, LIVN, and ITGR

Should you buy Kestra Medical Technologies stock or one of its competitors? Kestra Medical Technologies's main competitors and comparable companies include Teleflex (TFX), MiniMed Group (MMED), Haemonetics (HAE), LivaNova (LIVN), and Integer (ITGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Kestra Medical Technologies compare to Teleflex?

Teleflex (NYSE:TFX) and Kestra Medical Technologies (NASDAQ:KMTS) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

Teleflex has a net margin of -39.67% compared to Kestra Medical Technologies' net margin of -138.35%. Teleflex's return on equity of 11.93% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-39.67%	11.93%	5.44%
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%

In the previous week, Teleflex had 8 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 10 mentions for Teleflex and 2 mentions for Kestra Medical Technologies. Teleflex's average media sentiment score of 0.73 beat Kestra Medical Technologies' score of 0.58 indicating that Teleflex is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Kestra Medical Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Teleflex currently has a consensus target price of $152.90, indicating a potential upside of 9.16%. Kestra Medical Technologies has a consensus target price of $28.14, indicating a potential upside of 4.54%. Given Teleflex's higher probable upside, analysts clearly believe Teleflex is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Kestra Medical Technologies has lower revenue, but higher earnings than Teleflex. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	2.98	-$905.64M	-$23.29	N/A
Kestra Medical Technologies	$95.13M	16.58	-$131.61M	-$2.42	N/A

Teleflex has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

95.6% of Teleflex shares are owned by institutional investors. 0.7% of Teleflex shares are owned by insiders. Comparatively, 5.3% of Kestra Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Teleflex beats Kestra Medical Technologies on 11 of the 16 factors compared between the two stocks.

How does Kestra Medical Technologies compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Kestra Medical Technologies (NASDAQ:KMTS) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

MiniMed Group currently has a consensus target price of $21.62, suggesting a potential upside of 14.25%. Kestra Medical Technologies has a consensus target price of $28.14, suggesting a potential upside of 4.54%. Given MiniMed Group's stronger consensus rating and higher probable upside, analysts plainly believe MiniMed Group is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Kestra Medical Technologies has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	1.72	-$333M	-$0.68	N/A
Kestra Medical Technologies	$95.13M	16.58	-$131.61M	-$2.42	N/A

MiniMed Group has a net margin of 0.00% compared to Kestra Medical Technologies' net margin of -138.35%. MiniMed Group's return on equity of 0.00% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%

In the previous week, MiniMed Group had 4 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 6 mentions for MiniMed Group and 2 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.58 beat MiniMed Group's score of 0.44 indicating that Kestra Medical Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Kestra Medical Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

MiniMed Group beats Kestra Medical Technologies on 9 of the 13 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Haemonetics?

Kestra Medical Technologies (NASDAQ:KMTS) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

Kestra Medical Technologies currently has a consensus price target of $28.14, suggesting a potential upside of 4.54%. Haemonetics has a consensus price target of $97.56, suggesting a potential downside of 9.96%. Given Kestra Medical Technologies' higher probable upside, analysts clearly believe Kestra Medical Technologies is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

99.7% of Haemonetics shares are held by institutional investors. 5.3% of Kestra Medical Technologies shares are held by company insiders. Comparatively, 2.1% of Haemonetics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Kestra Medical Technologies has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

Haemonetics has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$95.13M	16.58	-$131.61M	-$2.42	N/A
Haemonetics	$1.33B	3.70	$97.31M	$2.04	53.11

Haemonetics has a net margin of 7.12% compared to Kestra Medical Technologies' net margin of -138.35%. Haemonetics' return on equity of 27.55% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%
Haemonetics	7.12%	27.55%	9.65%

In the previous week, Haemonetics had 11 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 13 mentions for Haemonetics and 2 mentions for Kestra Medical Technologies. Haemonetics' average media sentiment score of 0.96 beat Kestra Medical Technologies' score of 0.58 indicating that Haemonetics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kestra Medical Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Haemonetics	7 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Haemonetics beats Kestra Medical Technologies on 13 of the 17 factors compared between the two stocks.

How does Kestra Medical Technologies compare to LivaNova?

LivaNova (NASDAQ:LIVN) and Kestra Medical Technologies (NASDAQ:KMTS) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations.

97.6% of LivaNova shares are held by institutional investors. 0.4% of LivaNova shares are held by company insiders. Comparatively, 5.3% of Kestra Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

LivaNova has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market.

Kestra Medical Technologies has lower revenue, but higher earnings than LivaNova. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39B	3.15	-$242.47M	$3.38	23.49
Kestra Medical Technologies	$95.13M	16.58	-$131.61M	-$2.42	N/A

LivaNova currently has a consensus price target of $83.50, suggesting a potential upside of 5.15%. Kestra Medical Technologies has a consensus price target of $28.14, suggesting a potential upside of 4.54%. Given LivaNova's stronger consensus rating and higher possible upside, equities research analysts plainly believe LivaNova is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.55
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

LivaNova has a net margin of 12.82% compared to Kestra Medical Technologies' net margin of -138.35%. LivaNova's return on equity of 16.35% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	12.82%	16.35%	7.76%
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%

In the previous week, LivaNova had 4 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 6 mentions for LivaNova and 2 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.58 beat LivaNova's score of 0.14 indicating that Kestra Medical Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Kestra Medical Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

LivaNova beats Kestra Medical Technologies on 12 of the 16 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Integer?

Kestra Medical Technologies (NASDAQ:KMTS) and Integer (NYSE:ITGR) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

Kestra Medical Technologies has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market. Comparatively, Integer has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

99.3% of Integer shares are held by institutional investors. 5.3% of Kestra Medical Technologies shares are held by company insiders. Comparatively, 1.1% of Integer shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Kestra Medical Technologies presently has a consensus target price of $28.14, suggesting a potential upside of 4.54%. Integer has a consensus target price of $109.86, suggesting a potential downside of 12.43%. Given Kestra Medical Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe Kestra Medical Technologies is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

Integer has a net margin of 6.97% compared to Kestra Medical Technologies' net margin of -138.35%. Integer's return on equity of 12.79% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%
Integer	6.97%	12.79%	6.48%

In the previous week, Integer had 17 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 19 mentions for Integer and 2 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.58 beat Integer's score of 0.37 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kestra Medical Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integer has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$95.13M	16.58	-$131.61M	-$2.42	N/A
Integer	$1.85B	2.30	$102.81M	$3.66	34.28

Summary

Integer beats Kestra Medical Technologies on 10 of the 16 factors compared between the two stocks.

Get Kestra Medical Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KMTS vs. The Competition

Export

Metric	Kestra Medical Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.58B	$5.95B	$7.35B	$12.72B
Dividend Yield	N/A	1.74%	2.53%	11.02%
P/E Ratio	-11.12	26.05	270.96	24.14
Price / Sales	16.58	70.19	634.76	101.59
Price / Cash	N/A	33.27	78.57	53.12
Price / Book	6.05	6.27	13.14	6.25
Net Income	-$131.61M	$149.30M	$3.46B	$347.86M
7 Day Performance	-3.55%	0.27%	1.52%	0.98%
1 Month Performance	27.83%	9.20%	8.82%	5.24%
1 Year Performance	45.28%	6.86%	26.08%	17.04%

Kestra Medical Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KMTS Kestra Medical Technologies	1.6571 of 5 stars	$26.92 +0.0%	$28.14 +4.5%	+51.9%	$1.58B	$95.13M	N/A	300
TFX Teleflex	3.5217 of 5 stars	$138.99 +3.0%	$151.80 +9.2%	+9.6%	$5.72B	$1.99B	N/A	15,500	Analyst Forecast Short Interest Increase
MMED MiniMed Group	2.6585 of 5 stars	$20.45 +1.3%	$21.62 +5.7%	N/A	$5.67B	$3.10B	N/A	2,800	News Coverage
HAE Haemonetics	3.018 of 5 stars	$108.89 +0.6%	$97.56 -10.4%	+95.9%	$4.92B	$1.35B	53.38	3,009
LIVN LivaNova	2.65 of 5 stars	$78.74 +0.7%	$83.50 +6.0%	+40.9%	$4.31B	$1.39B	23.30	3,300	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KMTS) was last updated on 8/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kestra Medical Technologies (KMTS) Competitors

KMTS vs. TFX, MMED, HAE, LIVN, and ITGR

How does Kestra Medical Technologies compare to Teleflex?

Summary

How does Kestra Medical Technologies compare to MiniMed Group?

Summary

How does Kestra Medical Technologies compare to Haemonetics?

Summary

How does Kestra Medical Technologies compare to LivaNova?

Summary

How does Kestra Medical Technologies compare to Integer?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KMTS vs. The Competition

Kestra Medical Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kestra Medical Technologies (KMTS) Competitors

KMTS vs. TFX, MMED, HAE, LIVN, and ITGR

How does Kestra Medical Technologies compare to Teleflex?

Is TFX or KMTS more profitable?

Does the media refer more to TFX or KMTS?

Do analysts rate TFX or KMTS?

Which has higher earnings and valuation, TFX or KMTS?

Which has more risk & volatility, TFX or KMTS?

Do insiders & institutionals believe in TFX or KMTS?

Summary

How does Kestra Medical Technologies compare to MiniMed Group?

Do analysts prefer MMED or KMTS?

Which has stronger earnings and valuation, MMED or KMTS?

Is MMED or KMTS more profitable?

Does the media favor MMED or KMTS?

Summary

How does Kestra Medical Technologies compare to Haemonetics?

Do analysts rate KMTS or HAE?

Do institutionals and insiders hold more shares of KMTS or HAE?

Which has more risk & volatility, KMTS or HAE?

Which has stronger valuation & earnings, KMTS or HAE?

Is KMTS or HAE more profitable?

Does the media favor KMTS or HAE?

Summary

How does Kestra Medical Technologies compare to LivaNova?

Do insiders & institutionals hold more shares of LIVN or KMTS?

Which has more volatility and risk, LIVN or KMTS?

Which has higher valuation and earnings, LIVN or KMTS?

Do analysts recommend LIVN or KMTS?

Is LIVN or KMTS more profitable?

Does the media refer more to LIVN or KMTS?

Summary

How does Kestra Medical Technologies compare to Integer?

Which has more risk & volatility, KMTS or ITGR?

Do institutionals & insiders have more ownership in KMTS or ITGR?

Do analysts prefer KMTS or ITGR?

Is KMTS or ITGR more profitable?

Does the media prefer KMTS or ITGR?

Which has higher earnings and valuation, KMTS or ITGR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KMTS vs. The Competition

Kestra Medical Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools